European Patent for Orthopedic Pain Management Implant
Summary
The European Patent Office has published patent application EP2024186934A1 for an implantable interpositional orthopedic pain management device. The publication date is March 11, 2026, and the inventors have not yet been designated.
What changed
The European Patent Office (EPO) has published a patent application, EP2024186934A1, concerning an implantable interpositional orthopedic pain management device. This publication signifies the formal disclosure of the invention under patent law, making it publicly available. The application lists multiple European states as designated for patent protection, indicating a broad geographical interest within the EU.
While this is a patent publication and not a regulatory rule, it is relevant for medical device manufacturers and innovators in the prosthetics and orthopedic fields. Companies operating in these sectors should be aware of new patent filings that could impact their intellectual property landscape or product development strategies. No immediate compliance actions are required by this patent publication, but it highlights ongoing innovation in pain management implants.
Source document (simplified)
IMPLANTABLE INTERPOSITIONAL ORTHOPEDIC PAIN MANAGEMENT
Publication EP2024186934A1 Kind: A1 Mar 11, 2026
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
A61F 2/30 20060101AFI20240913BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Prosthetics (A61F) publishes new changes.